Blood Pressure Drugs May Dangerously Shift Stress Inside Diseased Arteries
Biology

Blood Pressure Drugs May Dangerously Shift Stress Inside Diseased Arteries

A computational model reveals that relaxing smooth muscle cells can unintentionally overload fragile fibrous caps in atherosclerotic plaques.

By Priya Sharma
Published:
Email this Article
Blood Pressure Drugs May Dangerously Shift Stress Inside Diseased Arteries
Amlodipine diffusion profile and its effects on myosin head fractions in the external iliac artery. (a) depicts the steady-state amlodipine concentration (μ​M\mathrm{\mu M}) profile. (b) shows the evolution of myosin head fractions (dashed: no drug; solid: with drug) for the attached, phosphorylated state nCn_{\text{C}}(red) and attached, dephosphorylated state nDn_{\text{D}}(green) at the material point marked in (a) by a cross. Corresponding drug concentration profile plotted in blue. Post-treatment, nCn_{\text{C}} reduces from 0.82 to 0.21, significantly reducing contraction Sharan Nurani Ramesh et al. / arXiv

When patients take medications to lower high blood pressure, their arteries generally relax, but a new computational study reveals an unexpected mechanical side effect that could carry hidden risks for vulnerable blood vessels. The research, available on the arXiv preprint server, shows that common blood pressure drugs can unintentionally shift physical stress onto fragile protective layers within diseased arteries.

Cardiovascular disease remains the leading cause of global mortality, taking approximately 19.8 million lives in 2022. Hypertension, or high blood pressure, affects roughly 1.28 billion adults aged 30 to 79 and stands as a major driver of premature death. To combat this crisis, millions of people rely on antihypertensive medications such as amlodipine, a widely prescribed calcium channel blocker that relaxes the smooth muscle cells in blood vessel walls.

While relaxing these muscles typically reduces overall tension and lowers blood pressure, atherosclerotic arteries feature complex plaque formations containing lipid pools, calcifications, and fibrous caps. Researchers Sharan Nurani Ramesh, Lea Saßmannshausen, Axel Klawonn, and Daniel Balzani built an advanced computational model to investigate how these drugs alter local mechanical forces inside diseased arteries. Their findings indicate that as smooth muscle cells relax, they shed their load-bearing duties, forcing neighboring structural components to pick up the slack.

How Blood Pressure Drugs Shift Mechanical Loads

To understand what happens inside a medicated vessel, the team developed a mathematical framework that couples drug transport, smooth muscle cell contraction, anisotropic tissue behavior, and residual stresses. The authors modeled how amlodipine diffuses through the arterial wall, inhibiting calcium channels and reducing the ability of smooth muscle cells to contract. They tested this model on five different human arterial geometries reconstructed from histological cross-sections, representing various stages of atherosclerosis and plaque morphology.

Figure 4: Arterial geometries constructed from histological cross-sections of atherosclerotic human arteries. (a) and (d) show coronary thin cap fibroatheromas with moderate stenosis taken from Narula et al. [89] and Phinikaridou et al. [96], respectively. (b) shows a tibial artery with severe stenosis, calcifications, and a large fibrous cap obtained from Kim and Guzman [71]. (c) depicts an external iliac artery with eccentric stenosis obtained from Holzapfel et al. [52]. (e) depicts a thick cap fibrous atheroma with moderate stenosis taken from Plasschaert et al. [98]. Exemplary boundary value problem is shown in (f): three nodes (in red) are fixed in the circumferential direction to prevent rigid body motion, the front and back faces (in pink) are fixed in the axial direction, while pressure is applied to the luminal surface
Arterial geometries constructed from histological cross-sections of atherosclerotic human arteries. (a) and (d) show coronary thin cap fibroatheromas with moderate stenosis taken from Narula et al. [89] and Phinikaridou et al. [96], respectively. (b) shows a tibial artery with severe stenosis, calcifications, and a large fibrous cap obtained from Kim and Guzman [71]. (c) depicts an external iliac artery with eccentric stenosis obtained from Holzapfel et al. [52]. (e) depicts a thick cap fibrous atheroma with moderate stenosis taken from Plasschaert et al. [98]. Exemplary boundary value problem is shown in (f): three nodes (in red) are fixed in the circumferential direction to prevent rigid body motion, the front and back faces (in pink) are fixed in the axial direction, while pressure is applied to the luminal surface Credit: Sharan Nurani Ramesh et al. / arXiv

The simulations demonstrate that while drug treatment successfully lowers stress in the medial layers of the artery, it simultaneously shifts mechanical loads directly onto the fibrous cap. In an external iliac artery simulation, the von Mises stress in the fibrous cap increased by a volume-weighted median of 28.9 kilopascals, with local peaks reaching up to 95 kilopascals. Similar stress increases occurred across multiple plaque morphologies, with the most severe jumps appearing in thin cap fibroatheromas.

Why Insufficient Pressure Drops Raise Rupture Concerns

The core danger of this load-shifting phenomenon depends heavily on how effectively the medication reduces systemic blood pressure. If a drug lowers blood pressure insufficiently, the increased mechanical burden on the fibrous cap remains unmitigated. The authors simulated blood pressure drops of 10, 20, and 30 millimeters of mercury to measure the offsetting effects of systemic relief.

Figure 6: Contour plots of von Mises stress (kPa) in the external iliac artery inflated to 85mmHg. (a) shows control stress levels, (b) the stress levels with amlodipine treatment, and (c) shows the difference in von Mises stress with and without amlodipine (σaml.−σcontrol\sigma_{\text{aml.}}-\sigma_{\text{control}}). As can be seen in (c), in the simulation with drug, von Mises stresses in the medial layers are lower than in the control, whereas those in the fibrous cap are considerably higher
Contour plots of von Mises stress (kPa) in the external iliac artery inflated to 85mmHg. (a) shows control stress levels, (b) the stress levels with amlodipine treatment, and (c) shows the difference in von Mises stress with and without amlodipine (σaml.−σcontrol\sigma_{\text{aml.}}-\sigma_{\text{control}}). As can be seen in (c), in the simulation with drug, von Mises stresses in the medial layers are lower than in the control, whereas those in the fibrous cap are considerably higher Credit: Sharan Nurani Ramesh et al. / arXiv

At a modest blood pressure reduction of 10 millimeters of mercury, the median stress increase in the fibrous cap dropped to 3.8 kilopascals or lower in four of the five tested geometries. When pressure drops reached 20 to 30 millimeters of mercury, the median change in stress turned neutral or negative in most arteries, meaning the benefits of lower blood pressure successfully offset the local stress increase. However, in specific geometries like the external iliac artery, moderate pressure drops still left residual stress increases of over 12 kilopascals.

What This Means for Plaque Stability and Future Treatments

An increase in fibrous cap stress does not automatically guarantee that a plaque will rupture, as the outcome depends on the intrinsic material strength of the cap itself. Human fibrous caps possess a wide strength range, spanning from 72 to 259 kilopascals. In cases where a plaque is already loaded close to its breaking point before treatment, a drug-induced stress increase could elevate the risk of rupture if blood pressure reduction is incomplete.

The researchers emphasize that major clinical trials have consistently shown long-acting calcium channel blockers to be safe and effective at reducing cardiovascular events. These large trials typically achieve sufficient blood pressure control, which aligns with the study’s finding that adequate pressure reduction neutralizes the stress shift. Nevertheless, the authors suggest that identifying patient-specific plaque vulnerabilities and ensuring optimal blood pressure control remain critical factors in designing safer therapeutic protocols.

The study was posted to the arXiv preprint server on November 16, 2026.

Fact Checked

This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.

Last reviewed on .

Article history

  • Latest version

Cite this page:

Sharma, Priya. “Blood Pressure Drugs May Dangerously Shift Stress Inside Diseased Arteries.” BioScience. BioScience ISSN 2521-5760, 17 November 2026. <https://www.bioscience.com.pk/en/subject/biology/pharmaco-mechanical-computational-simulation-of-atherosclerotic-arteries-effects-of-calcium-channel-blockers-on-local-stress-distributions>. Sharma, P. (2026, November 17). “Blood Pressure Drugs May Dangerously Shift Stress Inside Diseased Arteries.” BioScience. ISSN 2521-5760. Retrieved November 17, 2026 from https://www.bioscience.com.pk/en/subject/biology/pharmaco-mechanical-computational-simulation-of-atherosclerotic-arteries-effects-of-calcium-channel-blockers-on-local-stress-distributions Sharma, Priya. “Blood Pressure Drugs May Dangerously Shift Stress Inside Diseased Arteries.” BioScience. ISSN 2521-5760. https://www.bioscience.com.pk/en/subject/biology/pharmaco-mechanical-computational-simulation-of-atherosclerotic-arteries-effects-of-calcium-channel-blockers-on-local-stress-distributions (accessed November 17, 2026).
End of the article